Cargando…
Apoptosis of cardiomyocytes in diabetic cardiomyopathy involves overexpression of glycogen synthase kinase-3β
To evaluate the role of glycogen synthase kinase-3β (GSK-3β) in the apoptosis of cardiomyocytes in diabetic cardiomyopathy (DCM). Diabetes mellitus (DM) in rats was induced by intraperitoneal injection of 1% streptozotocin (STZ), and lithium chloride (LiCl) was used to decrease the expression of GSK...
Autores principales: | Wu, Wei, Liu, Xingxing, Han, Longfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328876/ https://www.ncbi.nlm.nih.gov/pubmed/30237226 http://dx.doi.org/10.1042/BSR20171307 |
Ejemplares similares
-
Glycogen Synthase Kinase-3β Is a Negative Regulator of Cardiomyocyte Hypertrophy
por: Haq, Syed, et al.
Publicado: (2000) -
The role of glycogen synthase kinase-3β in glioma cell apoptosis induced by remifentanil
por: Xu, Jing, et al.
Publicado: (2013) -
Glycogen synthase kinase 3β in tumorigenesis and oncotherapy
por: He, Rui, et al.
Publicado: (2020) -
Targeted disruption of glycogen synthase kinase-3β in cardiomyocytes attenuates cardiac parasympathetic dysfunction in type 1 diabetic Akita mice
por: Zhang, Yali, et al.
Publicado: (2019) -
Glycogen Synthase Kinase-3
por: Crouch, Peter, et al.
Publicado: (2011)